FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention represents a pharmaceutical composition for treating hypercholesteremia, triglyceridemia, ischemic heart disease (IHD) and prevention of myocardial infarction, stroke, atherosclerosis and reducing risk of unfavourable action of statins on blood glucose level, including, at least two active components, one component selected from group of statins: atorvastatin, lovastatin, Pravastatin, rosuvastatin, simvastatin, fluvastatin, pitavastatin, and second component is selected from group of prebiotics: xylitol, sorbitol, lactitol, lactulose, lactosucroze, melibioze, xylobioze, stachyose, raffinoze or galactooligosaccharide, maltooligosaccharide, xylooligosaccharide, isomalto-oligosaccharide, gentioligosaccharide, or arabinogalactan, pullulan, wherein components of composition are taken in certain proportions, mg.
EFFECT: invention provides efficient fixed combined preparation, reducing risk of diabetes mellitus, developing statins with underlying administration in therapy of such conditions as hypercholesterolemia, triglitzeridemia, ischemic heart disease, prevention of myocardial infarction, stroke and atherosclerosis, as well as solving problems of developing class-specific side effects of statins on carbohydrate metabolism and function of pancreas.
4 cl, 4 dwg, 6 ex
